SOPH — SOPHiA GENETICS SA
—
Nasdaq ·
Information Technology ·
IT Services ·
CIK 1840706 ·
Last close
$5.65
Market Cap
$474.01M
52W High
$6.30
52W Low
$4.44
ADV30
301,062
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 21,688,000 | 14,749,000 | -17,283,000 | -19,322,000 | 156,995,000 | 65,392,000 | 111,307,000 |
| Dec 2025 | 21,707,000 | 14,692,000 | -18,516,000 | -19,179,000 | 163,031,000 | 70,289,000 | 115,886,000 |
| Sep 2025 | 19,462,000 | 12,907,000 | -17,862,000 | -20,021,000 | 163,458,000 | 81,610,000 | 102,771,000 |
| Jun 2025 | 18,323,000 | 12,270,000 | -18,492,000 | -22,414,000 | 177,620,000 | 94,822,000 | 100,928,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-35,893,000
Investing CF
$-8,670,000
Financing CF
$30,177,000
CapEx
$-8,620,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-1.12
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-519,276,000
Inventory
$6,351,000
Receivables
$16,525,000
ST Investments
—
EBIT TTM
$-72,933,000
Pretax Income TTM
$-77,487,000
Interest Exp TTM
$4,554,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$81,180,000
EBITDA
$-70,322,000
Free Cash Flow
$-24,592,376
Enterprise Value
$414,852,928
Total Cash
$65,392,000
Total Debt
$62,425,000
Shares Out
83,895,266
Trailing EPS
$-1.18
Book Value
$0.64
ROE
-123.3%
ROA
-29.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 77,271,000 | -70,906,000 | -78,999,000 | 163,031,000 | 115,886,000 | — | -35,893,000 |
| Dec 2024 | 65,173,000 | -66,568,000 | -62,493,000 | 155,309,000 | 58,819,000 | — | -44,515,000 |
| Dec 2023 | 62,371,000 | -74,826,000 | -78,981,000 | 206,156,000 | 54,714,000 | — | -53,224,000 |
| Dec 2022 | 47,560,000 | -87,823,000 | -87,449,000 | 243,838,000 | 43,708,000 | — | -70,093,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.56
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MOVE | Corvex, Inc. | $464.00M | $16.79 | — |
| FCCN | SPECTRAL CAPITAL Corp | $505.46M | $5.25 | — |
| GRVY | GRAVITY Co., Ltd. | $443.34M | $63.80 | — |
| IBEX | IBEX Ltd | $443.05M | $33.09 | — |
| YEXT | Yext, Inc. | $510.26M | $5.09 | — |
News headlines (Yahoo Finance, 1h cache)
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
2026-06-23 19:38 · Yahoo
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
2026-06-22 12:25 · Yahoo
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
2026-06-19 12:00 · Yahoo
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
2026-06-17 01:21 · Yahoo
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
2026-06-16 20:20 · Yahoo
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
2026-06-10 12:00 · Yahoo
Insider Spends US$99k Buying More Shares In SOPHiA GENETICS
2026-06-07 13:47 · Yahoo
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
2026-06-04 12:00 · Yahoo
Undervalued Opportunities: Top Penny Stocks To Watch In May 2026
2026-05-21 12:05 · Yahoo
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
2026-05-13 09:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.